Podcast Episodes
Back to Search
Episode 316: APCCC 2024 Summary with Silke Gillessen
Season 3 Episode 316
Silke covers key aspects of the meeting, including surgery vs RT, genetic and somatic testing, PSMA imaging and 1st line triplet therapy.
2 years, 6 months ago
Episode 315: APCCC 2024 Quickfire - Bone health, hot flashes and gynecomastia in prostate cancer
Season 3 Episode 315
Chris Sweeney is joined by Matt Smith, Anthony Joshua and Lisa Horvath to discuss the management of these complex issues in advanced prostate cancer.
2 years, 6 months ago
Episode 314: APCCC 2024 Cardiovascular risks with hormone therapy in prostate cancer
Season 3 Episode 314
Thomas Suter and Chuck Ryan discuss identification and management of cardiovascular disease for patients starting therapy for prostate cancer.
2 years, 6 months ago
Episode 313: APCCC 2024 Debate - Radiation therapy in advanced disease
Season 3 Episode 313
Thomas Zilli and Pierre Blanchard discuss this topic from Lugano.
2 years, 6 months ago
Episode 312: APCCC 2024 Radiation therapy after surgery for prostate cancer
Season 3 Episode 312
Jason Efstathiou and Piet Ost discuss the data for and against this approach.
2 years, 6 months ago
Episode 311: The Uromigos Paper of the Month - The POUT Trial
Season 3 Episode 311
Alison Birtle describes adjuvant chemotherapy in bladder cancer.
2 years, 6 months ago
Episode 310: Dosing and duration of drugs from a cost perspective
Season 3 Episode 310
Daniel Goldstein describes his work on this issue.
2 years, 6 months ago
Episode 309: EAU24 Checkmate 274 - OS for adjuvant nivolumab in bladder cancer
Season 3 Episode 309
In this second part, Matt Galsky describes the OS signal data. We also look into the future.
2 years, 6 months ago
Episode 308: EAU24 IMVIGOR 011 - Outcome of ctDNA negative patients post-cystectomy
Season 3 Episode 308
Tom, Brian and Matt Galsky review the screening component of this study, presented at EAU24.
2 years, 6 months ago
Episode 307: Bladder-Sparing Approaches Part 2
Season 3 Episode 307
Michiel Van der Heijden explores the role of radiotherapy and other neoadjuvant and other neoadjuvant combinations to prevent the need for surgery.
2 years, 6 months ago